WELL Health Technologies (WELL) Stock Price, News & Analysis

Company Overview

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare. The company also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, it operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); Apps.health, a digital health app marketplace; billing and revenue cycle management solutions for billing and back-office services comprising billing-as-a-service outsourcing services to doctors; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, an EMR platform. The company was founded in 2010 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$6.90 to C$7.19
• 50-Day Range: C$4.37 to C$7.09
• 52-Week Range: C$3.41 to C$7.19
• Volume: 1.99 million shs
• Average Volume: 897,809 shs
• Market Capitalization: C$1.74 billion
• P/E Ratio: 12.28
• Dividend Yield: N/A
• Price Target: C$8.28
• Consensus Rating: Moderate Buy

WELL Health Technologies Stock Analysis - MarketRank™

WELL Health Technologies scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

WELL Health Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

WELL Health Technologies has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of WELL Health Technologies is 12.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of WELL Health Technologies is 12.28, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 133.45.

Price to Earnings Growth Ratio

Due to a projected decrease in earnings for WELL Health Technologies, their PEG ratio cannot be calculated.

Price to Book Value per Share Ratio

WELL Health Technologies has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for WELL.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

WELL Health Technologies does not currently pay a dividend.

Dividend Growth

WELL Health Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for WELL.

News and Social Media

• Score: 3.8 / 5
• News Sentiment: 0.80

News Sentiment

WELL Health Technologies has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 16 news articles for WELL Health Technologies this week, compared to 11 articles on an average week.

Search Interest

18 people have searched for WELL on MarketBeat in the last 30 days. This is an increase of 6% compared to the previous 30 days.

MarketBeat Follows

13 people have added WELL Health Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 550% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, WELL Health Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 6.80% of the stock of WELL Health Technologies is held by insiders.

Percentage Held by Institutions

Only 5.61% of the stock of WELL Health Technologies is held by institutions.

WELL Stock Analysis - Frequently Asked Questions

How have WELL shares performed this year?

WELL Health Technologies' stock was trading at C$3.85 on January 1st, 2024. Since then, WELL shares have increased by 81.8% and is now trading at C$7.00.
View the best growth stocks for 2024 here.

How do I buy shares of WELL Health Technologies?

Shares of WELL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of WELL Health Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that WELL Health Technologies investors own include Enbridge (ENB), NVIDIA (NVDA), Meta Platforms (META), Suncor Energy (SU), Toronto-Dominion Bank (TD), Shopify (SHOP) and PayPal (PYPL).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: Trading
• Current Symbol: TSE:WELL
• CUSIP: N/A
• CIK: N/A
• Web: www.well.company
• Phone: 604 628 7266
• Fax: N/A
• Employees: 510
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$8.28
• High Stock Price Target: C$11.00
• Low Stock Price Target: C$5.50
• Potential Upside/Downside: +17.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C$0.57
• Trailing P/E Ratio: 12.37
• Forward P/E Ratio: 23.49
• P/E Growth: -1.93
• Net Income: C$147.01 million
• Net Margins: 16.15%
• Pretax Margin: N/A
• Return on Equity: 18.34%
• Return on Assets: 2.07%

Debt

• Debt-to-Equity Ratio: 41.57
• Current Ratio: 1.25
• Quick Ratio: 1.02

Sales & Book Value

• Annual Sales: C$910.42 million
• Price / Sales: 1.93
• Cash Flow: C$0.57 per share
• Price / Cash Flow: 12.27
• Book Value: C$3.77 per share
• Price / Book: 1.87

Miscellaneous

• Outstanding Shares: 248,970,000
• Free Float: N/A
• Market Cap: C$1.76 billion
• Optionable: Not Optionable
• Beta: 1.20